Zdrowie i gospodarka · 09/08/2011

FDA Amends Animal Drug Regulations to Reflect Change in Moxidectin Sponsor

The Food and Drug Administration (FDA) is updating its regulations to reflect a change in sponsor for three approved new animal drug applications (NADAs) for moxidectin products from Fort Dodge Animal Health, a division of Wyeth, to Boehringer Ingelheim Vetmedica, Inc., a subsidiary of Pfizer, Inc.